The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Pharmaceutical plant opens in Oman
- Palmeiras U-19 to play in Morocco
- UAE horse championship to hold final in Brazil
- Brazil negotiates urea purchase from Indonesia
- Brazilian theater company and Morocco link
- Real estate mission to Dubai postponed to October
- Algeria opens bidding round for oil exploration
- Qatar to gradually resume foreign airline flights
